Cross-Modality Masked Learning for Survival Prediction in ICI Treated NSCLC Patients
Qilong Xing, Zikai Song, Bingxin Gong, Lian Yang, Junqing Yu, Wei Yang

TL;DR
This paper introduces a novel multi-modal fusion framework using cross-modality masked learning for improved survival prediction in NSCLC patients treated with immunotherapy, leveraging a large dataset of CT images and clinical data.
Contribution
It presents a new cross-modality masked learning approach with specialized transformers for CT and clinical data, enhancing multi-modal feature integration for prognosis.
Findings
Outperforms existing methods in survival prediction accuracy.
Sets a new benchmark for multi-modal prognostic models.
Demonstrates effective fusion of imaging and clinical data.
Abstract
Accurate prognosis of non-small cell lung cancer (NSCLC) patients undergoing immunotherapy is essential for personalized treatment planning, enabling informed patient decisions, and improving both treatment outcomes and quality of life. However, the lack of large, relevant datasets and effective multi-modal feature fusion strategies pose significant challenges in this domain. To address these challenges, we present a large-scale dataset and introduce a novel framework for multi-modal feature fusion aimed at enhancing the accuracy of survival prediction. The dataset comprises 3D CT images and corresponding clinical records from NSCLC patients treated with immune checkpoint inhibitors (ICI), along with progression-free survival (PFS) and overall survival (OS) data. We further propose a cross-modality masked learning approach for medical feature fusion, consisting of two distinct branches,…
Peer Reviews
No public reviews on file for this paper yet. If you reviewed it on a platform where reviews are public (OpenReview, ICLR, NeurIPS, ICML), you can paste yours below so the community can read it here.
Videos
No videos yet. Explain this paper in a talk, walkthrough, or lecture? Add one.
Taxonomy
TopicsRadiomics and Machine Learning in Medical Imaging · Lung Cancer Diagnosis and Treatment · Cancer Immunotherapy and Biomarkers
